Logo

American Heart Association

  2
  0


Final ID: 4145943

Recidivism in the Cardiac Intensive Care Unit: Insights from the Multinational Critical Care Cardiology Trials Network

Abstract Body (Do not enter title and authors here): Background: Intensive Care Unit (ICU) readmission, or recidivism, can lead to increased resource use, longer hospital length-of-stay (LOS), higher costs, & worse survival. Given the potential clinical & financial impact of recidivism, it may be a useful quality metric for unit- & hospital-level comparisons. No prior studies, however, have comprehensively explored recidivism – its potential causes or consequences – across Cardiac Intensive Care Units (CICUs).
Methods: The Critical Care Cardiology Trials Network (CCCTN) is a multicenter registry of advanced CICUs coordinated by the TIMI Study Group (Boston, MA). Consecutive admissions were captured (n=16,705) & those with >1 readmission during the same hospitalization were identified. Multivariable logistic regression was used to determine baseline variables associated with recidivism, as well as the association of recidivism with in-hospital mortality.
Results: A total of 1287 pts (7.7%) had CICU readmission. These pts were younger (p=0.015), had more diabetes (p=0.04), prior heart failure (HF) & chronic kidney disease (CKD) (p<0.001 for both), more frequently presented with decompensated HF or cardiogenic shock (p<0.001), were more often transferred from outside facilities (p<0.001), and had higher Sequential Organ Failure Assessment (SOFA) scores at presentation (p<0.001). Rates of CICU recidivism highly varied across institutions (Fig-A). Compared to those who were not readmitted, those readmitted to the CICU had greater critical care resource use during their 1st CICU stay (Fig-B), along with longer initial CICU LOS (2.8 vs 2.2d) & hospital LOS (20.4 vs 7.6d) (both p<0.001). Hospital mortality was 20.3% in those readmitted to the CICU compared to 4.5% in those without readmission (Fig-C); adjusted odds ratio 6.22 (95% CI 5.25-7.38, p<0.001). This remained statistically significant after adjustment for code status.
Conclusions: CICU recidivism varies significantly across centers and is associated with numerous comorbidities, higher illness severity, and greater resource use. One of every 5 pts readmitted to the CICU died in the hospital. Recidivism should be measured in future CICU-based studies, and could help to assess quality of CICU care.
  • Katz, Jason  ( NYU Langone , New York , New York , United States )
  • Palazzolo, Michael  ( TIMI Study Group , Boston , Massachusetts , United States )
  • Van Diepen, Sean  ( UNIVERSITY OF ALBERTA , Edmonton , Alberta , Canada )
  • Bohula, Erin  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Berg, David  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Morrow, David  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Sinha, Shashank  ( Inova Schar Heart and Vascular , Falls Church , Virginia , United States )
  • Alviar, Carlos  ( NYU Langone , New York , New York , United States )
  • Kontos, Michael  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
  • Carnicelli, Anthony  ( , Charleston , South Carolina , United States )
  • Daniels, Lori  ( UC San Diego , Del Mar , California , United States )
  • Pierce, Matthew  ( Northwell Health , Greenwich , Connecticut , United States )
  • Wang, Jeffrey  ( Emory University , Atlanta , Georgia , United States )
  • Baird-zars, Vivian  ( TIMI Study Group , Boston , Massachusetts , United States )
  • Author Disclosures:
    Jason Katz: DO have relevant financial relationships ; Researcher:Abbott Corporation:Active (exists now) ; Other (please indicate in the box next to the company name):Abiomed, DSMB Member:Active (exists now) ; Speaker:Zoll Corporation:Past (completed) | Michael Palazzolo: DO NOT have relevant financial relationships | Sean Van Diepen: DO NOT have relevant financial relationships | Erin Bohula: No Answer | David Berg: DO NOT have relevant financial relationships | David Morrow: No Answer | Shashank Sinha: DO NOT have relevant financial relationships | Carlos Alviar: No Answer | Michael Kontos: DO NOT have relevant financial relationships | Anthony Carnicelli: DO have relevant financial relationships ; Researcher:Acorai:Active (exists now) | Lori Daniels: DO have relevant financial relationships ; Consultant:QuidelOrtho:Active (exists now) ; Other (please indicate in the box next to the company name):Tosoh - Clinical Endpoint Adjudication Cmte:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott - Clinical Endpoint Adjudication Cmte:Active (exists now) ; Consultant:Roche Diagnostics:Active (exists now) | Matthew Pierce: DO NOT have relevant financial relationships | Jeffrey Wang: No Answer | Vivian Baird-Zars: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):I am a member of the TIMI Study Group which has received institutional research grant support through Brigham and Women’s Hospital from:Abbott, Abiomed, Inc., Amgen, Anthos Therapeutics, ARCA Biopharma, Inc., AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Ionis Pharmaceuticals, Inc., Janssen Research and Development, LLC, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche, Saghmos Therapeutics, Inc., Siemens Healthcare Diagnostics, Inc., Softcell Medical Limited, The Medicines Company, Verve Therapeutics, Inc., Zora Biosciences :Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Hear Ye Hear Ye! Arresting News in Critical Care Cardiology!!

Monday, 11/18/2024 , 08:00AM - 09:15AM

Abstract Oral Session

More abstracts on this topic:
A Stepwise Approach to Identifying and Assessing the Content Validity of Patient-Reported Outcome (PRO) Measures for Use with Adults with Acute Heart Failure

O'connor Meaghan, Loughlin Anita, Waldman Laura, Rucker Sloan, Vaghela Shailja, Kwon Namhee, Sikirica Vanja

Association between Pressure-Adjusted Heart Rate and Mortality in Cardiogenic Shock

Ginder Curtis, Jentzer Jacob, Guo Jianping, Van Diepen Sean, Katz Jason, Morrow David, Berg David

More abstracts from these authors:
Characterization of Isolated Right Ventricular Congestion in Cardiogenic Shock

Kaur Gurleen, Berg David, Van Diepen Sean, Katz Jason, Guo Jianping, Morrow David, Bohula Erin

Contemporary Practice Patterns of Vasoactive Agents in Cardiogenic Shock: An Analysis of the AHA Cardiogenic Shock Registry

Patel Siddharth, Berg David, Bohula Erin, Palazzolo Michael, Krucoff Mitchell, Morrow David

You have to be authorized to contact abstract author. Please, Login
Not Available